Stat Med
-
Publication Venue For
- Deep learning for the dynamic prediction of multivariate longitudinal and survival data.. 41:2894-2907. 2022
- Multilevel hybrid principal components analysis for region-referenced functional electroencephalography data. 2022
- Penalized weighted proportional hazards model for robust variable selection and outlier detection. 2022
- Bayesian inference and dynamic prediction of multivariate joint model with functional data: An application to Alzheimer's disease.. 40:6855-6872. 2021
- Bayesian hierarchical models for high-dimensional mediation analysis with coordinated selection of correlated mediators.. 40:6038-6056. 2021
- Sample size re-estimation in clinical trials.. 40:6133-6149. 2021
- On the robustness of latent class models for diagnostic testing with no gold standard.. 40:4751-4763. 2021
- Rejoinder to "On the robustness of latent class models for diagnostic testing with no gold standard".. 40:4770-4771. 2021
- Propensity score weighting for causal subgroup analysis.. 40:4294-4309. 2021
- On the design and the analysis of stratified biomarker trials in the presence of measurement error.. 40:2783-2799. 2021
- Bias testing, bias correction, and confounder selection using an instrumental variable model.. 39:4386-4404. 2020
- Sample size requirements for detecting treatment effect heterogeneity in cluster randomized trials.. 39:4218-4237. 2020
- Regression with a right-censored predictor using inverse probability weighting methods.. 39:4001-4015. 2020
- Sample size calculation for cluster randomization trials with a time-to-event endpoint.. 39:3608-3623. 2020
- Empirical use of causal inference methods to evaluate survival differences in a real-world registry vs those found in randomized clinical trials.. 39:3003-3021. 2020
- Secondary analysis of case-control association studies: Insights on weighting-based inference motivate a new specification test.. 39:2869-2882. 2020
- Predictive accuracy of markers or risk scores for interval censored survival data.. 39:2437-2446. 2020
- Matching with time-dependent treatments: A review and look forward.. 39:2350-2370. 2020
- Dynamic prediction of Alzheimer's disease progression using features of multiple longitudinal outcomes and time-to-event data.. 38:4804-4818. 2019
- Measures for evaluation of prognostic improvement under multivariate normality for nested and nonnested models.. 38:3817-3831. 2019
- Partitioning of time trends in prevalence and mortality of lung cancer.. 38:3184-3203. 2019
- A Bayesian approach for individual-level drug benefit-risk assessment.. 38:3040-3052. 2019
- Statistical methods for building better biomarkers of chronic kidney disease.. 38:1903-1917. 2019
- Estimating the association between blood pressure variability and cardiovascular disease: An application using the ARIC Study.. 38:1855-1868. 2019
- Power and sample size requirements for GEE analyses of cluster randomized crossover trials.. 38:636-649. 2019
- Single-number summary and decision analytic measures can happily coexist.. 38:499-500. 2019
- Auxiliary variable-enriched biomarker-stratified design.. 37:4610-4635. 2018
- Sample size calculation for studies with grouped survival data.. 37:3904-3917. 2018
- Authors' response to comments.. 36:4511-4513. 2017
- Discrimination slope and integrated discrimination improvement - properties, relationships and impact of calibration.. 36:4482-4490. 2017
- Net reclassification index at event rate: properties and relationships.. 36:4455-4467. 2017
- An evaluation of constrained randomization for the design and analysis of group-randomized trials with binary outcomes.. 36:3791-3806. 2017
- Functional joint model for longitudinal and time-to-event data: an application to Alzheimer's disease.. 36:3560-3572. 2017
- Asymptotic distribution of ∆AUC, NRIs, and IDI based on theory of U-statistics.. 36:3334-3360. 2017
- Multidimensional latent trait linear mixed model: an application in clinical studies with multivariate longitudinal outcomes.. 36:3244-3256. 2017
- On assessing bioequivalence and interchangeability between generics based on indirect comparisons.. 36:2978-2993. 2017
- A comparison of risk prediction methods using repeated observations: an application to electronic health records for hemodialysis.. 36:2750-2763. 2017
- Comparison of adaptive treatment strategies based on longitudinal outcomes in sequential multiple assignment randomized trials.. 36:403-415. 2017
- Comments on 'Estimands in clinical trials - broadening the perspective'.. 36:24-26. 2017
- Methods for assessing the reliability of quality of life based on SF-36.. 35:5656-5665. 2016
- Modeling zero-modified count and semicontinuous data in health services research Part 1: background and overview.. 35:5070-5093. 2016
- Modeling zero-modified count and semicontinuous data in health services research part 2: case studies.. 35:5094-5112. 2016
- Use of the landmark method to address immortal person-time bias in comparative effectiveness research: a simulation study.. 35:4824-4836. 2016
- Robust analysis of secondary phenotypes in case-control genetic association studies.. 35:4226-4237. 2016
- Assessing agreement with relative area under the coverage probability curve.. 35:3153-3165. 2016
- Bayesian reclassification statistics for assessing improvements in diagnostic accuracy.. 35:2574-2592. 2016
- An evaluation of constrained randomization for the design and analysis of group-randomized trials.. 35:1565-1579. 2016
- A hidden Markov model approach to analyze longitudinal ternary outcomes when some observed states are possibly misclassified.. 35:1549-1557. 2016
- Using pilot data to size a two-arm randomized trial to find a nearly optimal personalized treatment strategy.. 35:1245-1256. 2016
- Numeric score-based conditional and overall change-in-status indices for ordered categorical data.. 34:3622-3636. 2015
- Incorporation of individual-patient data in network meta-analysis for multiple continuous endpoints, with application to diabetes treatment.. 34:2794-2819. 2015
- Scan-stratified case-control sampling for modeling blood-brain barrier integrity in multiple sclerosis.. 34:2872-2880. 2015
- Comparison of operational characteristics for binary tests with clustered data.. 34:2325-2333. 2015
- Placebo non-response measure in sequential parallel comparison design studies.. 34:2281-2293. 2015
- Change point testing in logistic regression models with interaction term.. 34:1483-1494. 2015
- Power and sample size calculations for the Wilcoxon-Mann-Whitney test in the presence of death-censored observations.. 34:406-431. 2015
- A marginalized two-part model for semicontinuous data.. 33:4891-4903. 2014
- What to expect from net reclassification improvement with three categories.. 33:4975-4987. 2014
- Bayesian hierarchical model for multiple repeated measures and survival data: an application to Parkinson's disease.. 33:4279-4291. 2014
- How to interpret a small increase in AUC with an additional risk prediction marker: decision analysis comes through.. 33:3946-3959. 2014
- Net reclassification improvement and integrated discrimination improvement require calibrated models: relevance from a marker and model perspective.. 33:3415-3418. 2014
- Adjusting for misclassification in a stratified biomarker clinical trial.. 33:3100-3113. 2014
- Assessing the incremental predictive performance of novel biomarkers over standard predictors.. 33:2577-2584. 2014
- Joint model for a diagnostic test without a gold standard in the presence of a dependent terminal event.. 33:2554-2566. 2014
- Phase II clinical trials with time-to-event endpoints: optimal two-stage designs with one-sample log-rank test.. 33:2004-2016. 2014
- A global logrank test for adaptive treatment strategies based on observational studies.. 33:760-771. 2014
- A Bayesian approach to joint analysis of multivariate longitudinal data and parametric accelerated failure time.. 33:580-594. 2014
- Incidence estimation using a single cross-sectional age-specific prevalence survey with differential mortality.. 33:422-435. 2014
- Joint analysis of stochastic processes with application to smoking patterns and insomnia.. 32:5133-5144. 2013
- A hybrid method in combining treatment effects from matched and unmatched studies.. 32:4924-4937. 2013
- On model specification and selection of the Cox proportional hazards model.. 32:4609-4623. 2013
- Designs for randomized phase II clinical trials with two treatment arms.. 32:4367-4379. 2013
- Impact of correlation on predictive ability of biomarkers.. 32:4196-4210. 2013
- Robust Bayesian inference for multivariate longitudinal data by using normal/independent distributions.. 32:3812-3828. 2013
- Reply to taguri and matsuyama.. 32:3592-3593. 2013
- A repeated measures model for analysis of continuous outcomes in sequential parallel comparison design studies.. 32:2767-2789. 2013
- A Bayesian model for misclassified binary outcomes and correlated survival data with applications to breast cancer.. 32:2320-2334. 2013
- An information criterion for marginal structural models.. 32:1383-1393. 2013
- A weighted generalized score statistic for comparison of predictive values of diagnostic tests.. 32:964-977. 2013
- An adapted F-test for homogeneity of variability in follow-on biological products.. 32:415-423. 2013
- Application of the parallel line assay to assessment of biosimilar products based on binary endpoints.. 32:449-461. 2013
- Assessing biosimilarity and interchangeability of biosimilar products.. 32:361-363. 2013
- Comments on the FDA draft guidance on biosimilar products.. 32:364-369. 2013
- Impact of variability on the choice of biosimilarity limits in assessing follow-on biologics.. 32:424-433. 2013
- On the interchangeability of biologic drug products.. 32:434-441. 2013
- Scientific considerations for assessing biosimilar products.. 32:370-381. 2013
- Statistical assessment of biosimilarity based on relative distance between follow-on biologics.. 32:382-392. 2013
- Statistical methods for assessing interchangeability of biosimilars.. 32:442-448. 2013
- The evaluation of biosimilarity index based on reproducibility probability for assessing follow-on biologics.. 32:406-414. 2013
- A comparison of least squares and conditional maximum likelihood estimators under volume endpoint censoring in tumor growth experiments.. 31:4061-4073. 2012
- Adverse subpopulation regression for multivariate outcomes with high-dimensional predictors.. 31:4102-4113. 2012
- Variable selection for covariate-adjusted semiparametric inference in randomized clinical trials.. 31:3789-3804. 2012
- Misuse of DeLong test to compare AUCs for nested models.. 31:2577-2587. 2012
- A new permutation-based method for assessing agreement between two observers making replicated quantitative readings.. 31:2249-2261. 2012
- Designing a pilot sequential multiple assignment randomized trial for developing an adaptive treatment strategy.. 31:1887-1902. 2012
- Bayesian semiparametric regression models for evaluating pathway effects on continuous and binary clinical outcomes.. 31:1633-1651. 2012
- Quantifying discrimination of Framingham risk functions with different survival C statistics.. 31:1543-1553. 2012
- A framework for quantifying net benefits of alternative prognostic models.. 31:114-130. 2012
- Novel metrics for evaluating improvement in discrimination: net reclassification and integrated discrimination improvement for normal variables and nested models.. 31:101-113. 2012
- Estimation and testing of the relative risk of disease in case-control studies with a set of k matched controls per case with known prevalence of disease.. 31:29-44. 2012
- Assessing agreement with repeated measures for random observers.. 30:3546-3559. 2011
- Evaluation metrics for biostatistical and epidemiological collaborations.. 30:2767-2777. 2011
- A Bayesian growth mixture model to examine maternal hypertension and birth outcomes.. 30:2721-2735. 2011
- A min-max combination of biomarkers to improve diagnostic accuracy.. 30:2005-2014. 2011
- A few remarks on 'Statistical distribution of the difference of two proportions' by Nadarajah and Kotz, Statistics in Medicine 2007; 26(18):3518-3523.. 30:1913-1915. 2011
- Multiple testing of treatment-effect-modifying biomarkers in a randomized clinical trial with a survival endpoint.. 30:1502-1518. 2011
- Equivalence of improvement in area under ROC curve and linear discriminant analysis coefficient under assumption of normality.. 30:1410-1418. 2011
- On the C-statistics for evaluating overall adequacy of risk prediction procedures with censored survival data.. 30:1105-1117. 2011
- A new permutation-based method for assessing agreement between two observers making replicated binary readings.. 30:839-853. 2011
- Sample size calculations for evaluating a diagnostic test when the gold standard is missing at random.. 30:200. 2011
- Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers.. 30:11-21. 2011
- Analysis of multi-arm tumor growth trials in xenograft animals using phase change adaptive piecewise quadratic models.. 29:2399-2409. 2010
- Using Testlet Response Theory to analyze data from a survey of attitude change among breast cancer survivors.. 29:2028-2044. 2010
- Sample size calculations for evaluating a diagnostic test when the gold standard is missing at random.. 29:1572-1579. 2010
- Bayesian inference for the stereotype regression model: Application to a case-control study of prostate cancer.. 28:3139-3157. 2009
- Strategies for analyzing multilevel cluster-randomized studies with binary outcomes collected at varying intervals of time.. 27:6055-6071. 2008